PLSCR4
Basic information
Region (hg38): 3:146192335-146251179
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PLSCR4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 18 | 18 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 18 | 0 | 0 |
Variants in PLSCR4
This is a list of pathogenic ClinVar variants found in the PLSCR4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-146195255-T-C | not specified | Uncertain significance (Jan 02, 2024) | ||
3-146196666-G-A | not specified | Uncertain significance (Aug 30, 2022) | ||
3-146196703-T-C | not specified | Uncertain significance (Aug 02, 2021) | ||
3-146196726-G-A | not specified | Uncertain significance (May 14, 2024) | ||
3-146196750-G-A | not specified | Uncertain significance (Aug 08, 2023) | ||
3-146196762-A-G | not specified | Uncertain significance (Aug 17, 2022) | ||
3-146199841-C-A | not specified | Uncertain significance (Aug 04, 2023) | ||
3-146199844-C-T | not specified | Uncertain significance (Feb 15, 2023) | ||
3-146199863-G-T | not specified | Uncertain significance (Dec 20, 2023) | ||
3-146199865-C-T | not specified | Uncertain significance (Jun 13, 2023) | ||
3-146199893-T-C | not specified | Uncertain significance (May 24, 2023) | ||
3-146199917-A-C | not specified | Uncertain significance (Nov 20, 2023) | ||
3-146200034-T-C | not specified | Uncertain significance (Jan 16, 2024) | ||
3-146201041-G-C | not specified | Uncertain significance (May 15, 2024) | ||
3-146201067-A-G | not specified | Uncertain significance (Dec 14, 2022) | ||
3-146206564-T-C | not specified | Uncertain significance (Aug 02, 2023) | ||
3-146206579-G-A | Sensorineural hearing loss disorder | Uncertain significance (Sep 30, 2020) | ||
3-146206617-T-C | not specified | Uncertain significance (Apr 04, 2023) | ||
3-146206635-C-A | not specified | Uncertain significance (May 09, 2022) | ||
3-146206740-G-A | not specified | Uncertain significance (Nov 21, 2022) | ||
3-146220899-G-A | not specified | Uncertain significance (Apr 09, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PLSCR4 | protein_coding | protein_coding | ENST00000354952 | 8 | 58841 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000190 | 0.697 | 125637 | 0 | 110 | 125747 | 0.000437 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.431 | 170 | 187 | 0.911 | 0.00000943 | 2165 |
Missense in Polyphen | 51 | 58.726 | 0.86843 | 687 | ||
Synonymous | -0.367 | 64 | 60.4 | 1.06 | 0.00000298 | 615 |
Loss of Function | 1.12 | 11 | 15.8 | 0.697 | 7.51e-7 | 196 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00126 | 0.00123 |
Ashkenazi Jewish | 0.000310 | 0.000298 |
East Asian | 0.000637 | 0.000598 |
Finnish | 0.000534 | 0.000508 |
European (Non-Finnish) | 0.000330 | 0.000308 |
Middle Eastern | 0.000637 | 0.000598 |
South Asian | 0.000262 | 0.000261 |
Other | 0.00104 | 0.000978 |
dbNSFP
Source:
- Function
- FUNCTION: May mediate accelerated ATP-independent bidirectional transbilayer migration of phospholipids upon binding calcium ions that results in a loss of phospholipid asymmetry in the plasma membrane. May play a central role in the initiation of fibrin clot formation, in the activation of mast cells and in the recognition of apoptotic and injured cells by the reticuloendothelial system.;
Recessive Scores
- pRec
- 0.0974
Intolerance Scores
- loftool
- 0.910
- rvis_EVS
- 1.06
- rvis_percentile_EVS
- 91.58
Haploinsufficiency Scores
- pHI
- 0.102
- hipred
- N
- hipred_score
- 0.131
- ghis
- 0.432
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.902
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Plscr4
- Phenotype
Gene ontology
- Biological process
- plasma membrane phospholipid scrambling;cellular response to lipopolysaccharide
- Cellular component
- plasma membrane;integral component of membrane
- Molecular function
- calcium ion binding;protein binding;SH3 domain binding;phospholipid scramblase activity;enzyme binding;CD4 receptor binding